ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 924,97
-0,75%
Dow Jones
38 038,04
0,36%
DAX
17 920,45
-0,01%
Brent Oil
83,62
0,10%
Bitcoin
59 274,03
1,78%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PepGen Inc (PEPG)

  7. PepGen Inc (PEPG) Actualités

PEPG PepGen Inc

14,55
0,65 (4,68%)
Dernière mise à jour : 17:20:58
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
PepGen Inc PEPG NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,65 4,68% 14,55 17:20:58
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
14,00 13,41 14,55 13,90
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/3/202421:05GLOBEPepGen to Participate in Upcoming Investor Conferences
13/3/202412:00GLOBEPepGen Receives U.S. FDA Orphan Drug and Rare Pediatric..
06/3/202422:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202422:01GLOBEPepGen Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202422:00EDGAR2Form 8-K - Current report
04/3/202413:27EDGAR2Form 8-K - Current report
04/3/202413:00GLOBEPepGen Announces Clearance of CTA by UK Medicines &..
01/3/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202414:00EDGAR2Form 8-K - Current report
20/2/202414:00GLOBEPepGen Receives U.S. FDA Fast Track Designation for..
07/2/202422:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/2/202413:36EDGAR2Form 8-K - Current report
07/2/202413:30GLOBEPepGen Announces Pricing of $80.1 Million Underwritten..
17/1/202414:00EDGAR2Form 8-K - Current report
17/1/202413:00GLOBEMary Beth DeLena Joins PepGen as General Counsel and..
08/1/202413:00EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEPepGen Announces First Patient Dosed in CONNECT1-EDO51 Phase..
18/12/202314:00EDGAR2Form 8-K - Current report
18/12/202314:00GLOBEPepGen Announces First Patient Dosed in Phase 1 FREEDOM-DM1..
15/11/202314:00EDGAR2Form 8-K - Current report
15/11/202314:00GLOBEPepGen Announces Appointment of Howard Mayer, M.D. to Board..
08/11/202314:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202314:00EDGAR2Form 8-K - Current report
08/11/202314:00GLOBEPepGen Reports Third Quarter 2023 Financial Results and..
12/10/202313:52DJNFDA Lifts Hold on PepGen's New Drug Application for..
12/10/202313:05EDGAR2Form 8-K - Current report
12/10/202313:00GLOBEPepGen Inc. Announces FDA has Lifted the Clinical Hold on..
27/9/202322:16GLOBEPepGen Announces Upcoming Presentations at the 28th Annual..
06/9/202322:06EDGAR2Form 8-K - Current report
06/9/202322:05GLOBEPepGen Inc. Announces Clearance of CTA by Health Canada to..
06/9/202314:16EDGAR2Form 8-K - Current report
06/9/202314:00GLOBEPepGen Inc. Presents PGN-EDODM1 Preclinical Data Supporting..
01/9/202314:00GLOBEPepGen Announces Presentations at the 2023 Myotonic..
08/8/202314:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/8/202314:27EDGAR2Form 8-K - Current report
08/8/202314:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202314:15EDGAR2Form 8-K - Current report
08/8/202314:15GLOBEPepGen Reports Second Quarter 2023 Financial Results and..
13/6/202323:07DJNPepGen Withdraws Guidance on Launch of Study for Muscle..
13/6/202322:05GLOBEPepGen Inc. Provides Update on Planned Initiation of Phase 1..
30/5/202323:24DJNPepGen Shares Tumble 18.4% After FDA Issues Hold Notice on..
30/5/202322:05GLOBEPepGen Inc. Announces Clinical Hold in the U.S. on IND..
18/5/202313:00GLOBEPepGen Announces Clearance by Health Canada of CTA for..
11/5/202313:00GLOBEPepGen Reports First Quarter 2023 Financial Results and..
04/5/202314:00GLOBEPepGen to Participate in the Bank of America Securities 2023..

Dernières Valeurs Consultées

NASDAQ
PEPG
PepGen
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés